AvePoint, Inc.
AVPT Nasdaq Services-Prepackaged Software Financials FY2019βFY2025
What AvePoint, Inc. does
No business description yet.
- Legal name
- AvePoint, Inc.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Feb 26, 2026
- Accession Β· CIK
- 0001437749-26-005907
0001777921
Revenue and margins
AvePoint, Inc. had $419M of revenue in fiscal 2025, up 26.9% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $81.6M in fiscal 2025, 19.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
AvePoint, Inc. returned $49.8M to shareholders in fiscal 2025, 61% of free cash flow. The diluted share count rose 24.8%.
Balance sheet
Cash, debt and the ratios that show how comfortably AvePoint, Inc. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $271M | $230M | $227M | $291M | $481M |
| Current ratio | 3.0x | 2.1x | 1.8x | 1.8x | 2.3x |
| Quick ratio | 3.0x | 2.1x | 1.8x | 1.8x | 2.3x |
| Total assets | $389M | $416M | $443M | $519M | $789M |
| Total liabilities | $133M | $172M | $218M | $248M | $310M |
| Shareholders' equity | $250M | $229M | $219M | $271M | $479M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β | β |
| F-score | β / 3 | 4 / 8 | 4 / 8 | 2 / 8 | 5 / 8 | 4 / 8 | 5 / 8 |
| Accruals ratio | β5.1% | β13.8% | β14.4% | β10.2% | β13.1% | β24.5% | β7.7% |
| Altman Z'' | β6.33 | β6.65 | 1.66 | 0.04 | β0.36 | 0.21 | 2.72 |
7 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|
| Income statement | |||||||
| Revenue | $116M | $152M | $192M | $232M | $272M | $330M | $419M |
| Net interest income | β | β | $0.1M | β$0.0M | $0.0M | $0.2M | $4.6M |
| Provision for credit losses | β | β | β | β | $0.0M | $0.0M | $4.0M |
| Gross profit | $79.7M | $111M | $139M | $166M | $194M | $248M | $311M |
| Research and development | $11.1M | $12.2M | $32.1M | $31.4M | $36.3M | $48.7M | $52.6M |
| Operating income | β$19.0M | β$15.4M | β$53.5M | β$41.1M | β$15.4M | $7.2M | $33.0M |
| Pretax income | β$19.6M | β$15.9M | β$32.8M | β$33.7M | β$18.6M | β$24.4M | $40.5M |
| Income tax | $0.6M | $1.1M | $0.5M | $5.0M | $2.9M | $4.7M | $5.4M |
| Net income | β$20.2M | β$17.0M | β$35.2M | β$41.6M | β$21.7M | β$29.1M | $34.8M |
| Net income to common | β$128M | β$51.4M | β$68.1M | β$41.6M | β$21.7M | β$29.1M | $34.8M |
| Diluted EPS | β$1.72 | β$0.57 | β$0.48 | β | β$0.12 | β$0.16 | $0.15 |
| Diluted shares | 0.07B | 0.09B | 0.14B | 0.18B | 0.18B | 0.18B | 0.23B |
| Cash flow | |||||||
| Cash from operations | β$2.1M | $19.1M | $5.0M | β$0.8M | $34.7M | $88.9M | $85.3M |
| Capital expenditure | $1.1M | $1.0M | $2.5M | $3.9M | $2.1M | $3.0M | $3.7M |
| Free cash flow | β$3.1M | $18.1M | $2.6M | β$4.6M | $32.6M | $85.9M | $81.6M |
| Depreciation and amortization | $1.0M | $1.1M | $1.2M | $2.1M | $2.6M | $2.9M | $3.0M |
| Stock-based compensation | $13.9M | $33.8M | $59.5M | $37.2M | $36.0M | $39.1M | $39.3M |
| Acquisitions | β | β | $0.0M | $18.6M | $0.0M | $0.0M | $14.9M |
| Share buybacks | $0.0M | $0.0M | $1.6M | $19.9M | $39.0M | $33.1M | $49.8M |
| Dividends and buybacks | $0.0M | $0.0M | $1.6M | $19.9M | $39.0M | $33.1M | $49.8M |
| Balance sheet | |||||||
| Cash and short-term investments | $1.0M | $70.1M | $271M | $230M | $227M | $291M | $481M |
| Current assets | $1.2M | $121M | $334M | $306M | $326M | $395M | $625M |
| Current liabilities | $0.6M | $92.2M | $111M | $143M | $177M | $223M | $274M |
| Property and equipment, net | β | $2.7M | $3.9M | $5.5M | $5.1M | $5.3M | $6.0M |
| Goodwill | β | β | $0.0M | $18.9M | $19.2M | $17.7M | $38.0M |
| Intangible assets | β | β | $0.0M | $11.1M | $10.5M | $8.9M | $12.1M |
| Total assets | $353M | $169M | $389M | $416M | $443M | $519M | $789M |
| Total liabilities | $34.7M | $149M | $133M | $172M | $218M | $248M | $310M |
| Shareholders' equity | β$199M | β$193M | $250M | $229M | $219M | $271M | $479M |
| Margins | |||||||
| Gross margin | 68.6% | 73.4% | 72.4% | 71.5% | 71.5% | 75.0% | 74.1% |
| Operating margin | β16.4% | β10.2% | β27.9% | β17.7% | β5.6% | 2.2% | 7.9% |
| EBITDA margin | β15.5% | β9.5% | β27.2% | β16.8% | β4.7% | 3.0% | 8.6% |
| Net margin | β17.4% | β11.2% | β18.4% | β17.9% | β8.0% | β8.8% | 8.3% |
| FCF margin | β2.7% | 11.9% | 1.3% | β2.0% | 12.0% | 26.0% | 19.4% |
| Net interest share of revenue | β | β | 0.1% | β0.0% | 0.0% | 0.1% | 1.1% |
| Returns | |||||||
| Return on capital employed | β5.4% | β20.1% | β19.3% | β15.1% | β5.8% | 2.4% | 6.4% |
| Return on equity | β | β | β122.4% | β17.4% | β9.7% | β11.9% | 9.3% |
| Return on assets | β5.7% | β6.5% | β12.6% | β10.4% | β5.1% | β6.1% | 5.3% |
| Return on tangible equity | β | β | β27.2% | β20.9% | β11.5% | β11.9% | 8.1% |
| Growth | |||||||
| Revenue growth | β | 30.5% | 26.6% | 21.1% | 17.0% | 21.6% | 26.9% |
| FCF growth | β | β | β85.8% | β280.1% | β | 163.3% | β5.0% |
| Share count change | β | 21.1% | 58.0% | 28.5% | 0.2% | 0.8% | 24.8% |
| Financial health | |||||||
| Current ratio | 1.9x | 1.3x | 3.0x | 2.1x | 1.8x | 1.8x | 2.3x |
| Quick ratio | 1.9x | 1.3x | 3.0x | 2.1x | 1.8x | 1.8x | 2.3x |
| Capital allocation | |||||||
| Capex / revenue | 0.9% | 0.7% | 1.3% | 1.7% | 0.8% | 0.9% | 0.9% |
| Stock comp / revenue | 12.0% | 22.3% | 31.0% | 16.0% | 13.3% | 11.8% | 9.4% |
| Payouts / FCF | β | 0.0% | 63.4% | β | 119.7% | 38.5% | 61.0% |
| Quality scores | |||||||
| Piotroski F-score | β | 4.0 | 4.0 | 2.0 | 5.0 | 4.0 | 5.0 |
| Altman Z'' | β6.3 | β6.6 | 1.7 | 0.0 | β0.4 | 0.2 | 2.7 |
| Accruals ratio | β5.1% | β13.8% | β14.4% | β10.2% | β13.1% | β24.5% | β7.7% |
Source: SEC EDGAR XBRL filings (CIK 0001777921). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.